Health Condition 1: M179- Osteoarthritis of knee, unspecified
Conditions
Interventions
Intervention1: Liposomal Curcumin: Twice a day for 30 days
Control Intervention1: NA: NA
Sponsors
SSV Phytopharmaceuticals
Eligibility
Inclusion criteria
Inclusion criteria: Men and non-pregnant women who are at least 20 years and under 75 years of age; and Diagnosed with knee OA as determined by American College of Rheumatology (ACR) criteria Pain defined by a level of greater than or equal to 5 on Numeric Pain Rating Scale (NPRS) Patients who are, in the opinion of the Investigator, able to comply with the requirements of the study; and Patients who have been adequately informed of the nature and risks of the study and who have given written informed consent prior to receiving study medication.
Exclusion criteria
Exclusion criteria: Women who are pregnant, as determined by a urine pregnancy test, or breast-feeding. Presence or history of congestive heart failure (NYHA class III/IV) within the prior 12 weeks. Recent myocardial infarction (within the prior 12 weeks). Unstable angina pectoris. Known or suspected renal insufficiency defined as creatinine >1.5mg/dl.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the pain index was measured on Numeric Pain Rating Scale (NPRS) and Western Ontario and McMaster University Osteoarthritis Index [WOMAC] pain scoreTimepoint: 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety and efficacyTimepoint: 30 days | — |
Countries
India
Contacts
Public ContactDr Akhil Chaudhari
Vakratund Hospital
Outcome results
None listed